Cargando…
The Alveolar Lipidome in Pulmonary Alveolar Proteinosis. A New Target for Therapeutic Development?
Autores principales: | Trapnell, Bruce C., McCarthy, Cormac |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Thoracic Society
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6812441/ https://www.ncbi.nlm.nih.gov/pubmed/31162934 http://dx.doi.org/10.1164/rccm.201905-1009ED |
Ejemplares similares
-
Prevalence and healthcare burden of pulmonary alveolar proteinosis
por: McCarthy, Cormac, et al.
Publicado: (2018) -
Statin as a novel pharmacotherapy of pulmonary alveolar proteinosis
por: McCarthy, Cormac, et al.
Publicado: (2018) -
The parallel lives of alpha(1)-antitrypsin deficiency and pulmonary alveolar proteinosis
por: Trapnell, Bruce C, et al.
Publicado: (2013) -
Lipid-Laden Macrophages Are Not Diagnostic of Pulmonary Alveolar Proteinosis Syndrome and Can Indicate Lung Injury
por: McCarthy, Cormac, et al.
Publicado: (2020) -
Pulmonary alveolar proteinosis: An autoimmune disease lacking an HLA association
por: Anderson, Kirsten, et al.
Publicado: (2019)